SmartKem, Inc. Announces Private Placement Amendment and Additional Closings

What Happened

• SmartKem, Inc. (SMTK) filed an 8‑K reporting changes and recent closings under a Securities Purchase Agreement first entered on March 30, 2026. The agreement allows institutional buyers to purchase up to 21,411.5 shares of Series A convertible preferred stock and accompanying warrants for an aggregate purchase price of up to $17,129,200 (approx. $17.13M).
• On July 16, 2026 the Company executed Amendment No. 1 to the purchase agreement to permit a new buyer to join and to reallocate the number of Series A preferred shares and warrants among buyers for future additional closings. The amendment did not change the overall aggregate amount available under the agreement.
• The Company completed multiple closings: an initial closing on March 30, 2026 and additional closings on June 22, 2026 and July 16, 2026, resulting in approximately $5.0 million of cash proceeds to the Company.

Key Details

• Initial closing (March 30, 2026): Issued 11,411.5 shares of Series A preferred stock (stated value $1,000 per share) and warrants to purchase up to 23,251,960 shares of common stock.
• Additional closings: June 22, 2026 — 5,000 Series A shares and 10,753,615 warrants for ~ $4.0M cash; July 16, 2026 — 1,250 Series A shares and 2,688,404 warrants for ~ $1.0M cash (combined ~ $5.0M).
• The agreement permits buyers, subject to conditions, to require one or more Additional Closings for up to an aggregate of 10,000 more Series A shares and related warrants.
• Securities were issued in private placements relying on Section 4(a)(2) and/or Rule 506 of Regulation D (unregistered securities); they are not registered for resale in the U.S.

Why It Matters

• Liquidity: The recent additional closings provided roughly $5.0M in cash to SmartKem, which affects near‑term liquidity and funding for operations.
• Potential dilution: The issuance of convertible preferred stock plus very large warrant pools (tens of millions of common‑share purchase rights) could be dilutive to existing common shareholders if converted/exercised; investors should monitor conversion/exercise terms and potential impact on share count.
• Structure and flexibility: The amendment allows a new institutional buyer and reallocates purchase rights among buyers without increasing the total raise, preserving the overall financing framework agreed in March 2026.
• Regulatory note: These sales were private and unregistered; resale will be limited absent registration or an applicable exemption.